A recent randomized controlled pilot study suggests that Baduanjin, a traditional Chinese mind-body exercise, may help alleviate menopausal symptoms and fatigue in breast cancer patients undergoing aromatase inhibitor therapy. The study, published in Translational Exercise Biomedicine (ISSN: 2942-6812), an official partner journal of International Federation of Sports Medicine (FIMS).

Researchers at Rice University have engineered living cells to use a 21st amino acid that illuminates protein changes in real time, providing a new method for observing changes within cells. The technique is effective in bacteria, human cells and live tumor models, making it possible to study complex diseases like cancer more ethically. The findings are pending publication in Nature Communications Oct. 23.

The Alliance for Clinical Trials in Oncology has launched a new clinical trial to explore if using two targeted medications can help slow tumor growth in people with advanced adrenocortical carcinoma (ACC), a rare and aggressive cancer of the adrenal glands. In the study (Alliance A092204), researchers will test whether combining two medications (cabozantinib and cemiplimab) can help slow the growth of ACC and improve outcomes for patients whose cancer has spread or returned after treatment.

A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed.

In a recent study published in the journal Nature, researchers at Fox Chase Cancer Center have uncovered a new mechanism by which the body’s immune system responds to viral infections, a finding that can potentially be harnessed to attack cancer.

High levels of a specific protein can reduce the growth of tumour cells in neuroblastoma, a form of cancer that affects the sympathetic nervous system in young children. This is shown in a new study by researchers at Umeå University and Karolinska Institutet, Sweden. The protein in question also seems to cause the cancer cells to change into less aggressive cells